IMMUNOHISTOCHEMISTRY, CYCLIN-D1

The IHC – Cyclin D1 test is an immunohistochemistry-based diagnostic assay used to detect Cyclin D1 protein expression in tissue samples. Cyclin D1 is a cell cycle regulatory protein that controls the transition of cells from the G1 phase to the S phase during cell division. Abnormal overexpression of Cyclin D1 is associated with several cancers and plays an important role in tumor development.

This test is widely used in pathology and hematopathology to diagnose mantle cell lymphoma (MCL), where Cyclin D1 overexpression is considered a characteristic finding. It is also useful in evaluating certain solid tumors, including breast, parathyroid, and head and neck cancers.

Benefits of the Test

• Helps diagnose mantle cell lymphoma
• Assists in tumor classification and characterization
• Supports evaluation of abnormal cell proliferation
• Improves diagnostic accuracy in hematological malignancies
• Helps guide treatment planning and prognosis assessment

Why Doctors Recommend This Test

Doctors recommend the IHC Cyclin D1 test when there is suspicion of lymphoma or tumors associated with abnormal cell cycle regulation. It is commonly used in:

• Diagnosis of mantle cell lymphoma
• Evaluation of lymph node biopsies
• Classification of B-cell lymphomas
• Assessment of breast and head & neck tumors
• Oncology and hematopathology investigations

Cyclin D1 is often used together with markers such as CD5, CD20, CD23, SOX11, Ki-67, and BCL-2 to achieve accurate diagnosis and tumor profiling.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting or medication restrictions are needed
• Clinical history and previous pathology findings may aid interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected mantle cell lymphoma
• Individuals with enlarged lymph nodes requiring evaluation
• Cases requiring lymphoma classification
• Patients undergoing cancer biopsy analysis
• Oncology patients requiring immunohistochemistry profiling

The IHC Cyclin D1 test is an important diagnostic tool in oncology and hematopathology. By identifying abnormal Cyclin D1 expression, it helps pathologists accurately diagnose mantle cell lymphoma and other tumors, supporting effective treatment planning and patient management.

Clinical Significance

Cyclin D1 immunostaining is particularly valuable for:

• Mantle cell lymphoma diagnosis
• Differentiation of B-cell lymphomas
• Tumor proliferation assessment
• Cell cycle regulation studies
• Selected solid tumor evaluations